课题基金 / 基金详情

Identification of genes associated with poor prognosis

Identification of genes associated with poor prognosis
鉴定与不良预后相关的基因
批准号:
15590058
负责人:
KITAGAWA Kyoko
金额:
$2.24万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

KITAGAWA Kyoko的其他基金

相似基金

相关文献

中文摘要
翻译
细胞周期蛋白依赖性激酶(CDK)抑制剂p27^1;Kip1>是细胞的关键负性调节因子。P27;;Kip1>降解激活G1期细胞周期蛋白-CDK复合体,促进细胞周期由G1期进入S期。许多临床研究表明,p27^<Kip1>在许多类型的人类癌症中表达降低,包括乳腺癌和结直肠癌,并与其高侵袭性和不良预后密切相关。P27;;Kip1和gt;在人类肿瘤中的表达水平降低是由于泛素-蛋白酶体途径促进了p27;;kip1和gt;的降解。研究表明,p27^lt;Kip1>是一种SCF型泛素连接酶,它通过26S蛋白酶体泛素化p27^;lt;Kip1>以泛素依赖的降解为靶点,促进p27^<Kip1>的降解,但在p27^<Kip1>-低表达的肿瘤中,其高侵袭性或预后不良的原因尚不清楚。为了解决这个问题,我们试图确定哪些基因的表达受到p27^;;Kip1>-表达下调的影响。在本研究中,我们对人结肠癌细胞系HCT116进行了p27^;;Kip1>基因的靶向性干扰,以期建立p27;;kip1>低表达的模型细胞系。我们发现了一个基因PPAG4,它是由p27^<Kip1>-表达降低而诱导的。
英文摘要
A cyclin-dependent kinase (CDK) inhibitor p27^<Kip1> acts as a critical negative regulator of the cell. Degradation of p27^<Kip1> activates G1 cyclin-CDK complexes to promote the cell cycle progression from the G1 to S phase. Many clinical studies have indicated that reduced expression of p27^<Kip1> is found in many types of human cancers, including breast and colorectal carcinomas and highly associated with their high aggressiveness and poor prognosis. The decreased level of p27^<Kip1> expression in human cancers is due to enhanced degradation of p27^<Kip1> via ubiquitin-proteasome pathway. It is demonstrated that degradation of p27^<Kip1> is promoted by SCF^<Skp2>, an SCF-type ubiquitin ligase, which ubiquitinates p27^<Kip1> to target ubiquitin-dependent degradation through the 26S-proteasome However, it is unknown the cause of high aggressiveness or poor prognosis in the tumors with low p27^<Kip1>-expression. To solve the mater, we tried to identify the genes which expressions were affected by the reduction of p27^<Kip1>-expression. In the present study, we performed targeted disruption of human p27^<Kip1> gene in HCT116, human colorectal carcinoma cell lines in order to establish a model cell line with low expression of p27^<Kip1>. We found a gene, PPAG4, which was induced by the reduction of p27^<Kip1>-expression.
期刊论文(62)
专著(0)
科研奖励(0)
会议论文
Inui, N.et al.: "High expression of Cks1 in human non-small cell lung carcinomas"Biochem.Biophys.Rex.Commun. 303. 978-984 (2003)
Inui, N.等人:“人类非小细胞肺癌中 Cks1 的高表达”Biochem.Biophys.Rex.Commun。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: 10.1128/mcb.24.19.8418-8427.2004
发表时间: 2004-10-01
期刊: MOLECULAR AND CELLULAR BIOLOGY
影响因子: 5.3
作者: [Naito, M, Katayama, R, Tsuruo, T]
通讯作者: Tsuruo, T
Contribution of the constitutive and inducible degradation of Smad3 by the ubiquitin-proteasome pathway to transforming growth factor-β signaling.
泛素-蛋白酶体途径对 Smad3 的组成型和诱导型降解对转化生长因子-β 信号传导的贡献。
DOI: --
发表时间: 2004
期刊: J.Interferon & Cytokine Research 24
影响因子: --
作者: [Chiharu Uchida et al., Makio Hayakawa et al., Yasumichi Inoue et al.]
通讯作者: Yasumichi Inoue et al.
Hattori, T. et al.: "Cks1 is degraded via the ubiquitin-proteasome pathway in a cell cycle-dependent manner."Genes to Cells. 8. 889-896 (2003)
Hattori, T. 等人:“Cks1 通过泛素-蛋白酶体途径以细胞周期依赖性方式降解。”基因到细胞。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 29 条
    Analysis of the novel function of SCF-Fbw7
    • 批准号:
      24570151
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.49万
    • 财政年份:
      2012
    • 负责人:
      KITAGAWA Kyoko
    • 依托单位:
    The analysis of the correlation between the increase of Pirh2 expression and cancer progress
    • 批准号:
      21590062
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2009
    • 负责人:
      KITAGAWA Kyoko
    • 依托单位:
    Evaluation of GPR48 as a novel molecular target which is involved in the tumor progression
    • 批准号:
      19590064
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2007
    • 负责人:
      KITAGAWA Kyoko
    • 依托单位:
    Analysis of p27 responsive gene as a novel molecular therapeutic target
    • 批准号:
      17590056
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.3万
    • 财政年份:
      2005
    • 负责人:
      KITAGAWA Kyoko
    • 依托单位:
    国内基金
    海外基金
    胞浆p27Kip1蛋白经非常规途径分泌的分子机制及其在儿童急性淋巴细胞白血病复发与耐药中作用的研究
    • 批准号:
      81970135
    • 项目类别:
      面上项目
    • 资助金额:
      55.0万元
    • 批准年份:
      2019
    • 负责人:
      崔蕾
    • 依托单位:
    调控p27Kip1基因表达诱导小鼠前庭支持细胞增殖的作用
    • 批准号:
      81900929
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2019
    • 负责人:
      郭婧滢
    • 依托单位:
    对于细胞周期调控蛋白p27Kip1在视神经再生中的调控机制和功能研究
    • 批准号:
      81770937
    • 项目类别:
      面上项目
    • 资助金额:
      51.0万元
    • 批准年份:
      2017
    • 负责人:
      熊文君
    • 依托单位:
    LncRNA SNHG6调控STMN1/p27Kip1促进卵巢癌恶性进展的作用和机制研究
    • 批准号:
      81702562
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      21.0万元
    • 批准年份:
      2017
    • 负责人:
      王毅宏
    • 依托单位: